NO20031371L - Nye indolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents
Nye indolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende demInfo
- Publication number
- NO20031371L NO20031371L NO20031371A NO20031371A NO20031371L NO 20031371 L NO20031371 L NO 20031371L NO 20031371 A NO20031371 A NO 20031371A NO 20031371 A NO20031371 A NO 20031371A NO 20031371 L NO20031371 L NO 20031371L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- compositions containing
- indoline compounds
- Prior art date
Links
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000005605 benzo group Chemical group 0.000 abstract 2
- -1 cyano, nitro, hydroxy, amino Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Pregnancy & Childbirth (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Forbindelser med formel (I):. hvori: Rog Rsammen danner en benzoring eventuelt substituert med et halogenatom eller med en alkyl-, alkoksy-, cyano-, nitro-, hydroksy-, amino-, alkylamino-, dialkylamino- eller trifluormetylgruppe, og Rrepresenterer et hydrogenatom, eller Rrepresenterer et hydrogenatom, og Rog Rdanner sammen en benzoring eventuelt substituert med et halogenatom eller med en alkyl-, alkoksy-, cyano-, nitro-, hydroksy-, amino-, alkylamino-, dialkylamino- eller trifluormetyl- gruppe, og addisjonssalter derav med en farmasøytisk akseptabel syre eller base.Medikamenter.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0203788A FR2837823B1 (fr) | 2002-03-27 | 2002-03-27 | Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20031371D0 NO20031371D0 (no) | 2003-03-26 |
| NO20031371L true NO20031371L (no) | 2003-09-29 |
| NO324761B1 NO324761B1 (no) | 2007-12-10 |
Family
ID=8871507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031371A NO324761B1 (no) | 2002-03-27 | 2003-03-26 | Nye indolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6759421B2 (no) |
| EP (1) | EP1348704B1 (no) |
| JP (1) | JP3926284B2 (no) |
| KR (1) | KR100562207B1 (no) |
| CN (1) | CN1209359C (no) |
| AR (1) | AR039145A1 (no) |
| AT (1) | ATE326457T1 (no) |
| AU (1) | AU2003203287B2 (no) |
| BR (1) | BR0300759A (no) |
| CA (1) | CA2423820C (no) |
| CY (1) | CY1105509T1 (no) |
| DE (1) | DE60305229T2 (no) |
| DK (1) | DK1348704T3 (no) |
| EA (1) | EA005620B1 (no) |
| ES (1) | ES2263927T3 (no) |
| FR (1) | FR2837823B1 (no) |
| MX (1) | MXPA03002532A (no) |
| NO (1) | NO324761B1 (no) |
| NZ (1) | NZ524958A (no) |
| PL (1) | PL208281B1 (no) |
| PT (1) | PT1348704E (no) |
| SI (1) | SI1348704T1 (no) |
| ZA (1) | ZA200302392B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101005534B1 (ko) * | 2008-06-23 | 2011-01-04 | (주)핼릭스케어 | 충격 흡수력이 우수한 인솔 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4704693A (en) * | 1992-08-20 | 1994-03-15 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists |
| GB9313913D0 (en) * | 1993-07-06 | 1993-08-18 | Smithkline Beecham Plc | Novel compounds |
| WO1995029177A1 (en) * | 1994-04-23 | 1995-11-02 | Smithkline Beecham P.L.C. | Tricyclic derivatives as 5ht2c and 5ht2b antagonists |
| US6221884B1 (en) * | 1997-06-04 | 2001-04-24 | Eli Lilly And Company | Carboxamides useful as 5-HT1F agonists |
| FR2807754A1 (fr) * | 2000-04-13 | 2001-10-19 | Adir | Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2002
- 2002-03-27 FR FR0203788A patent/FR2837823B1/fr not_active Expired - Fee Related
-
2003
- 2003-03-24 MX MXPA03002532A patent/MXPA03002532A/es active IP Right Grant
- 2003-03-26 PT PT03290759T patent/PT1348704E/pt unknown
- 2003-03-26 EP EP03290759A patent/EP1348704B1/fr not_active Expired - Lifetime
- 2003-03-26 AR ARP030101050A patent/AR039145A1/es unknown
- 2003-03-26 DE DE60305229T patent/DE60305229T2/de not_active Expired - Lifetime
- 2003-03-26 EA EA200300302A patent/EA005620B1/ru not_active IP Right Cessation
- 2003-03-26 ES ES03290759T patent/ES2263927T3/es not_active Expired - Lifetime
- 2003-03-26 BR BR0300759-6A patent/BR0300759A/pt not_active IP Right Cessation
- 2003-03-26 SI SI200330286T patent/SI1348704T1/sl unknown
- 2003-03-26 PL PL359357A patent/PL208281B1/pl not_active IP Right Cessation
- 2003-03-26 NZ NZ524958A patent/NZ524958A/en not_active IP Right Cessation
- 2003-03-26 AT AT03290759T patent/ATE326457T1/de active
- 2003-03-26 NO NO20031371A patent/NO324761B1/no not_active IP Right Cessation
- 2003-03-26 DK DK03290759T patent/DK1348704T3/da active
- 2003-03-26 CA CA 2423820 patent/CA2423820C/fr not_active Expired - Fee Related
- 2003-03-27 CN CNB031211844A patent/CN1209359C/zh not_active Expired - Fee Related
- 2003-03-27 AU AU2003203287A patent/AU2003203287B2/en not_active Ceased
- 2003-03-27 US US10/400,358 patent/US6759421B2/en not_active Expired - Fee Related
- 2003-03-27 JP JP2003086786A patent/JP3926284B2/ja not_active Expired - Fee Related
- 2003-03-27 KR KR1020030019207A patent/KR100562207B1/ko not_active Expired - Fee Related
- 2003-03-27 ZA ZA200302392A patent/ZA200302392B/xx unknown
-
2004
- 2004-03-30 US US10/813,347 patent/US7053108B2/en not_active Expired - Fee Related
-
2006
- 2006-07-11 CY CY20061100964T patent/CY1105509T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60225671D1 (de) | Pharmazeutisch wirksame piperidinderivate | |
| UA90269C2 (ru) | Тетрагидрохинолиновые производные и способ их получения | |
| NO20091889L (no) | Inhibitorer av spiroketon acetyl-CoA karboksylase | |
| NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
| MXPA05006740A (es) | Imidazoquinolinas arilo-sustituidas. | |
| NO20092033L (no) | Nye forbindelser | |
| HUP0202787A2 (hu) | 5-HT1B antagonista piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| CO5580770A2 (es) | Compuestos de quinolina terapeuticos con propiedades antagonistas de 5-ht | |
| MY139887A (en) | Tetrahydronaphthyridine derivatives and a process for preparing the same. | |
| DK1506185T3 (da) | Forbindelser og deres anvendelse som 5-HT-inhibitorer | |
| NO20052710L (no) | Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| AR036602A1 (es) | Agonistas muscarinicos | |
| NO20051047L (no) | Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater | |
| NO20031371L (no) | Nye indolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DK0880520T3 (da) | Benzo[c]quinolinderivater, deres fremstilling af anvendelse som 5-alfa-reduktaseinhibitorer | |
| NO20083753L (no) | Nye pyridinylaminoalkylen- og pyridinyloksyalkylen-syklopropanaminer, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende dem | |
| NO20055167L (no) | Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| EP1559716A4 (en) | PYRAZOLONAPHTHYRIDINDERIVAT | |
| NO20041761L (no) | Nye hydroksyalkylindolokarbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| PE20030345A1 (es) | 3,5-dihidroxi-2,2-dimetil-valeroamidas protegidas para la sintesis de epotilonas y derivados y un procedimiento para su preparacion | |
| EA200200379A2 (ru) | Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции | |
| NO20045540L (no) | Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem | |
| NO20074942L (no) | Nye fosfinaminosyreforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20023381L (no) | Indolderivater som MCP-1-reseptoragonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |